Körber

AMTSOL delivers technology solutions for pharmaceutical and biotechnology manufacturers, specialising in the digitalization and automation of GMP-regulated manufacturing environments. The company's work spans the full stack of manufacturing systems - from Level 2 automation through to Level 5 cloud integration and data analytics - and covers the complete project lifecycle, from consultancy and implementation to validation and continuous improvement. Its core service areas include Manufacturing Execution Systems (MES), OT networking, automation, cloud integration, data analytics, and both Computerized System Validation (CSV) and Commissioning, Qualification, and Validation (CQV) services. AMTSOL operates as a vendor-independent, single-partner provider, taking full responsibility for consultancy, project support, and ongoing optimisation across each engagement. GMP compliance and data integrity are central to its delivery model. The company works with pharmaceutical and biotechnology organisations across Singapore, Europe, and the United States, with a focus on Pharma 4.0 adoption and digital transformation. Its stated operational priorities include helping regulated manufacturers increase speed to market and improve operating efficiency.

Schweitzer Engineering Laboratories, Inc. (SEL) invents, designs, manufactures, and supports digital products and systems that protect, automate, control, and monitor critical electric power infrastructure. The company's founder invented the first microprocessor-based digital protective relay - a development that made reliable transmission line protection available at a fraction of the cost of traditional electromechanical equipment. Today, SEL's portfolio covers the full range of power system protection, control, monitoring, and automation for utilities and industrial customers worldwide. SEL is headquartered in Pullman, Washington, and manufactures all of its products in the United States across five manufacturing centers. Its customers span more than 170 countries, supported by a network of over 100 offices worldwide. The company backs its products with a ten-year worldwide warranty. With over 7,000 employee owners, SEL operates as a 100% employee-owned company. That structure shapes its stated priorities: long-term customer value over short-term financial results, and a sustained focus on quality, integrity, and technical support. Employee ownership is not a benefit program but the fundamental ownership model of the business.

Rapta is an applied AI software company focused on industrial manufacturing. Its core product, the AI Supercoach platform, runs entirely on-premises - deployed directly on factory floors - and uses video and sensor data to automate quality control, QA inspection, and operator training for both line workers and robotic processes. Because all data processing happens within the customer's facility, no data ever leaves the site. The platform is designed for rapid deployment: it can be operational in as little as 10 minutes, with full system setup achievable in under a day. Rapta claims its customers can achieve 30% more production capacity, reduce error costs by over 90%, and automate tasks up to 30 times faster. The platform is configurable across different manufacturing workflows and use cases, including building drones, industrial electronics, and defense systems. A notable feature is the real-time operator training capability, which is designed to work across language and literacy differences - making it applicable to diverse factory workforces. The company positions itself as a tool for addressing quality and productivity challenges in American manufacturing, with a stated focus on supporting the return of production work to the United States. Rapta's technical domains span applied AI, edge computing, computer vision, sensor data analytics, and integration with industrial automation and robotic processes. The company markets its approach as making AI deployment straightforward for manufacturers tackling complex production and inspection challenges.

Founded in 1992, Omnicell is a healthcare technology company focused on transforming how medications are managed across pharmacy settings. Its central ambition is the Autonomous Pharmacy - a model that combines automation, intelligence, and expert services to optimise clinical and business outcomes for healthcare organisations worldwide. The company's portfolio rests on four pillars: Robotics that remove human interaction from dangerous or repetitive medication management tasks Smart devices that close gaps in safety and inventory visibility Intelligent software that delivers data insights to optimise the pharmacy supply chain, including inventory management solutions Expert services designed to help customers extract maximum value from Omnicell technology Omnicell's solutions are deployed across a range of clinical environments - inpatient central pharmacies, IV rooms, points of care, outpatient specialty pharmacies, retail pharmacies, and medication adherence programmes. The company serves healthcare facilities globally; Baptist Health Alabama, for example, reported $425,000 in savings through Omnicell's intelligent inventory solutions. The company's work sits at the intersection of automation, robotics, data analytics, and pharmacy supply chain optimisation. Its stated aim is to reduce the potential for human error, streamline clinical workflows, and free clinicians to spend more time on direct patient care rather than medication management.

Cartesian is an MIT spinout building indoor spatial intelligence for retail environments. We're tackling one of the biggest operational challenges in the $35 trillion retail industry: in-store inventory visibility. Our platform delivers precise indoor positioning and actionable product location insights by fusing wireless signals and mobile computer vision, creating a uniquely scalable solution that requires no new infrastructure and can be deployed in minutes rather than months. Founded in 2023 by an MIT engineering professor and alum behind award-winning, patented core technologies, we've bootstrapped from research to a live product deployed across nearly 700 stores in over a dozen countries. Originally backed by the NSF SBIR Award, we're now aggressively scaling with international fashion brands. Our team works in-person at Kendall Square in Cambridge, where we move fast, ship features every two weeks, and care deeply about solving real problems that matter to our customers.

3M Company, founded in 1902 as a small mining venture in Minnesota, has grown into a Fortune 500 science and manufacturing conglomerate operating in over 70 countries with more than 90,000 employees. The company develops and manufactures products across a wide range of industries, including healthcare, electronics, consumer goods, automotive, safety, and energy. The company's technical foundation rests on 49 distinct technology platforms spanning disciplines such as adhesives, abrasives, ceramics, and nanotechnology. This breadth of expertise has produced a portfolio of over 100,000 patents and a product catalogue that includes both industrial solutions and widely recognised consumer items such as Post-it Notes, Scotch Tape, and Command Strips. Roughly one-third of 3M's sales come from products introduced within the previous five years. 3M's research and development operations are central to its business model. The company applies science across its technology platforms to address challenges in manufacturing, healthcare, safety, and everyday consumer use, translating laboratory work into products deployed at scale globally.